Nanomedicines Market 2027 By Product, Application, Type, and Geography | The Insight Partners

Nanomedicines Market to 2027 - Global Analysis and Forecasts by Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, and Vaccines); Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Other Applications); Type (Nanoparticles, Nanoshells, Nanotubes, and Nanodevices), and Geography

Report Code: TIPRE00004589 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The application of nanotechnology in the medical field is called nanomedicine. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. These can pass directly through the cellular membranes and interact with the cellular DNA and proteins, giving better desired results as compared to the traditional form of medicines. These nanomedicines are normally used across applications such as, diagnosis, targeted drug delivery and imaging.

MARKET DYNAMICS
The nanomedicines market is anticipated to grow in the forecast period owing to driving factors such as, large amount of R&D happen in this field and the rising number of cases of cancer. The new applications of nanodevices are expected to offer significant growth opportunities in the global nanomedicines market during the forecast period.

MARKET SCOPE
The "Global Nanomedicines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of nanomedicines market with detailed market segmentation by product, application, type, and geography. The global nanomedicines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nanomedicines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global nanomedicines market is segmented on the basis of product, application and type. Based on product, the market is classified as therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines. On the basis of application, the market is classified as clinical oncology, infectious diseases, clinical cardiology, orthopedics, and other applications. On the basis of type, the market is categorized as nanoparticles, nanoshells, nanotubes and nanodevices.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global nanomedicines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nanomedicines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting nanomedicines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nanomedicines market in these regions.

MARKET PLAYERS
The reports cover key developments in the nanomedicines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from nanomedicines market are anticipated to lucrative growth opportunities in the future with the rising demand for nanomedicines market in the global market. Below mentioned is the list of few companies engaged in the nanomedicines market.

The report also includes the profiles of key nanomedicines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AstraZeneca
  • Cristal Therapeutics
  • Ablynx (A Subsidiary Of Sanofi Company)
  • BlueWillow Biologics
  • Pfizer Inc.
  • CYTIMMUNE SCIENCES, INC.
  • NANOBIOTIX
  • Sirnaomics, Inc.
  • Starpharma Holdings Limited
  • Taiwan Liposome Company, Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nanomedicines Market - By Product
1.3.2 Nanomedicines Market - By Application
1.3.3 Nanomedicines Market - By Type
1.3.4 Nanomedicines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NANOMEDICINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NANOMEDICINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NANOMEDICINES MARKET - GLOBAL MARKET ANALYSIS
6.1. NANOMEDICINES - GLOBAL MARKET OVERVIEW
6.2. NANOMEDICINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. THERAPEUTICS
7.3.1. Overview
7.3.2. Therapeutics Market Forecast and Analysis
7.4. REGENERATIVE MEDICINE
7.4.1. Overview
7.4.2. Regenerative Medicine Market Forecast and Analysis
7.5. IN-VITRO DIAGNOSTICS
7.5.1. Overview
7.5.2. In-Vitro Diagnostics Market Forecast and Analysis
7.6. IN-VIVO DIAGNOSTICS
7.6.1. Overview
7.6.2. In-Vivo Diagnostics Market Forecast and Analysis
7.7. VACCINES
7.7.1. Overview
7.7.2. Vaccines Market Forecast and Analysis
8. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CLINICAL ONCOLOGY
8.3.1. Overview
8.3.2. Clinical Oncology Market Forecast and Analysis
8.4. INFECTIOUS DISEASES
8.4.1. Overview
8.4.2. Infectious Diseases Market Forecast and Analysis
8.5. CLINICAL CARDIOLOGY
8.5.1. Overview
8.5.2. Clinical Cardiology Market Forecast and Analysis
8.6. ORTHOPEDICS
8.6.1. Overview
8.6.2. Orthopedics Market Forecast and Analysis
8.7. OTHER APPLICATIONS
8.7.1. Overview
8.7.2. Other Applications Market Forecast and Analysis
9. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
9.1. OVERVIEW
9.2. TYPE MARKET FORECASTS AND ANALYSIS
9.3. NANOPARTICLES
9.3.1. Overview
9.3.2. Nanoparticles Market Forecast and Analysis
9.3.3. Metal and Metal Oxide Nanoparticles Market
9.3.3.1. Overview
9.3.3.2. Metal and Metal Oxide Nanoparticles Market Forecast and Analysis
9.3.4. Liposomes Market
9.3.4.1. Overview
9.3.4.2. Liposomes Market Forecast and Analysis
9.3.5. Polymers and Polymer Drug Conjugates Market
9.3.5.1. Overview
9.3.5.2. Polymers and Polymer Drug Conjugates Market Forecast and Analysis
9.3.6. Hydrogel Nanoparticles Market
9.3.6.1. Overview
9.3.6.2. Hydrogel Nanoparticles Market Forecast and Analysis
9.3.7. Dendrimers Market
9.3.7.1. Overview
9.3.7.2. Dendrimers Market Forecast and Analysis
9.3.8. Inorganic Nanoparticles Market
9.3.8.1. Overview
9.3.8.2. Inorganic Nanoparticles Market Forecast and Analysis
9.4. NANOSHELLS
9.4.1. Overview
9.4.2. Nanoshells Market Forecast and Analysis
9.5. NANOTUBES
9.5.1. Overview
9.5.2. Nanotubes Market Forecast and Analysis
9.6. NANODEVICES
9.6.1. Overview
9.6.2. Nanodevices Market Forecast and Analysis
10. NANOMEDICINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Nanomedicines Market Overview
10.1.2 North America Nanomedicines Market Forecasts and Analysis
10.1.3 North America Nanomedicines Market Forecasts and Analysis - By Product
10.1.4 North America Nanomedicines Market Forecasts and Analysis - By Application
10.1.5 North America Nanomedicines Market Forecasts and Analysis - By Type
10.1.6 North America Nanomedicines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Nanomedicines Market
10.1.6.1.1 United States Nanomedicines Market by Product
10.1.6.1.2 United States Nanomedicines Market by Application
10.1.6.1.3 United States Nanomedicines Market by Type
10.1.6.2 Canada Nanomedicines Market
10.1.6.2.1 Canada Nanomedicines Market by Product
10.1.6.2.2 Canada Nanomedicines Market by Application
10.1.6.2.3 Canada Nanomedicines Market by Type
10.1.6.3 Mexico Nanomedicines Market
10.1.6.3.1 Mexico Nanomedicines Market by Product
10.1.6.3.2 Mexico Nanomedicines Market by Application
10.1.6.3.3 Mexico Nanomedicines Market by Type
10.2. EUROPE
10.2.1 Europe Nanomedicines Market Overview
10.2.2 Europe Nanomedicines Market Forecasts and Analysis
10.2.3 Europe Nanomedicines Market Forecasts and Analysis - By Product
10.2.4 Europe Nanomedicines Market Forecasts and Analysis - By Application
10.2.5 Europe Nanomedicines Market Forecasts and Analysis - By Type
10.2.6 Europe Nanomedicines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Nanomedicines Market
10.2.6.1.1 Germany Nanomedicines Market by Product
10.2.6.1.2 Germany Nanomedicines Market by Application
10.2.6.1.3 Germany Nanomedicines Market by Type
10.2.6.2 France Nanomedicines Market
10.2.6.2.1 France Nanomedicines Market by Product
10.2.6.2.2 France Nanomedicines Market by Application
10.2.6.2.3 France Nanomedicines Market by Type
10.2.6.3 Italy Nanomedicines Market
10.2.6.3.1 Italy Nanomedicines Market by Product
10.2.6.3.2 Italy Nanomedicines Market by Application
10.2.6.3.3 Italy Nanomedicines Market by Type
10.2.6.4 Spain Nanomedicines Market
10.2.6.4.1 Spain Nanomedicines Market by Product
10.2.6.4.2 Spain Nanomedicines Market by Application
10.2.6.4.3 Spain Nanomedicines Market by Type
10.2.6.5 United Kingdom Nanomedicines Market
10.2.6.5.1 United Kingdom Nanomedicines Market by Product
10.2.6.5.2 United Kingdom Nanomedicines Market by Application
10.2.6.5.3 United Kingdom Nanomedicines Market by Type
10.2.6.6 Rest of Europe Nanomedicines Market
10.2.6.6.1 Rest of Europe Nanomedicines Market by Product
10.2.6.6.2 Rest of Europe Nanomedicines Market by Application
10.2.6.6.3 Rest of Europe Nanomedicines Market by Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Nanomedicines Market Overview
10.3.2 Asia-Pacific Nanomedicines Market Forecasts and Analysis
10.3.3 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Type
10.3.6 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Nanomedicines Market
10.3.6.1.1 Australia Nanomedicines Market by Product
10.3.6.1.2 Australia Nanomedicines Market by Application
10.3.6.1.3 Australia Nanomedicines Market by Type
10.3.6.2 China Nanomedicines Market
10.3.6.2.1 China Nanomedicines Market by Product
10.3.6.2.2 China Nanomedicines Market by Application
10.3.6.2.3 China Nanomedicines Market by Type
10.3.6.3 India Nanomedicines Market
10.3.6.3.1 India Nanomedicines Market by Product
10.3.6.3.2 India Nanomedicines Market by Application
10.3.6.3.3 India Nanomedicines Market by Type
10.3.6.4 Japan Nanomedicines Market
10.3.6.4.1 Japan Nanomedicines Market by Product
10.3.6.4.2 Japan Nanomedicines Market by Application
10.3.6.4.3 Japan Nanomedicines Market by Type
10.3.6.5 South Korea Nanomedicines Market
10.3.6.5.1 South Korea Nanomedicines Market by Product
10.3.6.5.2 South Korea Nanomedicines Market by Application
10.3.6.5.3 South Korea Nanomedicines Market by Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Nanomedicines Market Overview
10.4.2 Middle East and Africa Nanomedicines Market Forecasts and Analysis
10.4.3 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Type
10.4.6 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Nanomedicines Market
10.4.6.1.1 South Africa Nanomedicines Market by Product
10.4.6.1.2 South Africa Nanomedicines Market by Application
10.4.6.1.3 South Africa Nanomedicines Market by Type
10.4.6.2 Saudi Arabia Nanomedicines Market
10.4.6.2.1 Saudi Arabia Nanomedicines Market by Product
10.4.6.2.2 Saudi Arabia Nanomedicines Market by Application
10.4.6.2.3 Saudi Arabia Nanomedicines Market by Type
10.4.6.3 U.A.E Nanomedicines Market
10.4.6.3.1 U.A.E Nanomedicines Market by Product
10.4.6.3.2 U.A.E Nanomedicines Market by Application
10.4.6.3.3 U.A.E Nanomedicines Market by Type
10.4.6.4 Rest of Middle East and Africa Nanomedicines Market
10.4.6.4.1 Rest of Middle East and Africa Nanomedicines Market by Product
10.4.6.4.2 Rest of Middle East and Africa Nanomedicines Market by Application
10.4.6.4.3 Rest of Middle East and Africa Nanomedicines Market by Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Nanomedicines Market Overview
10.5.2 South and Central America Nanomedicines Market Forecasts and Analysis
10.5.3 South and Central America Nanomedicines Market Forecasts and Analysis - By Product
10.5.4 South and Central America Nanomedicines Market Forecasts and Analysis - By Application
10.5.5 South and Central America Nanomedicines Market Forecasts and Analysis - By Type
10.5.6 South and Central America Nanomedicines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Nanomedicines Market
10.5.6.1.1 Brazil Nanomedicines Market by Product
10.5.6.1.2 Brazil Nanomedicines Market by Application
10.5.6.1.3 Brazil Nanomedicines Market by Type
10.5.6.2 Argentina Nanomedicines Market
10.5.6.2.1 Argentina Nanomedicines Market by Product
10.5.6.2.2 Argentina Nanomedicines Market by Application
10.5.6.2.3 Argentina Nanomedicines Market by Type
10.5.6.3 Rest of South and Central America Nanomedicines Market
10.5.6.3.1 Rest of South and Central America Nanomedicines Market by Product
10.5.6.3.2 Rest of South and Central America Nanomedicines Market by Application
10.5.6.3.3 Rest of South and Central America Nanomedicines Market by Type
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NANOMEDICINES MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CRISTAL THERAPEUTICS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABLYNX (A SUBSISDIARY OF SANOFI COMPANY)
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. 4. BLUEWILLOW BIOLOGICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CYTIMMUNE SCIENCES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NANOBIOTIX
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SIRNAOMICS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. STARPHARMA HOLDINGS LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TAIWAN LIPOSOME COMPANY, LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. Cristal Therapeutics
3. Ablynx (A Subsidiary Of Sanofi Company)
4. BlueWillow Biologics
5. Pfizer Inc.
6. CYTIMMUNE SCIENCES, INC.
7. NANOBIOTIX
8. Sirnaomics, Inc.
9. Starpharma Holdings Limited
10. Taiwan Liposome Company, Ltd.